Expert highlights need for more research to better understand sarcopenic obesity

A new condition, that occurs in the presence of both sarcopenia and obesity and termed as "sarcopenic obesity", and that describes under the same phenotype the increase in body fat mass deposition, and the reduction in lean mass and muscle strength.

Recently, Professor Marwan El Ghoch from the Department of Nutrition & Dieitics at Beirut Arab University - Lebanon, in a short communication recently published in The Open Nutrition Journal highlighted that many uncertainties still surround the condition of sarcopenic obesity in terms of definition, adverse health effects and clinical management via three important questions:

  • 1)What is the definition of sarcopenic obesity?

    2)Is sarcopenic obesity harmful to health?

    3)Is this condition worth treating?

In this direction he suggested a flow chart regard the best approach to the study the sarcopenic obesity, and emphasized some crucial aspects that future research should take into account in order to avoid bias and misinterpretations.

Finally Professor El Ghoch, concluded by underlining that the study of sarcopenic obesity should be considered a scientific and clinical priority, as reported by two important bodies: the European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO).​

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Diabetes drug semaglutide proves beneficial for patients with chronic kidney damage and obesity